Suppr超能文献

新生儿短暂性呼吸急促采用鼻间歇强制通气与鼻持续气道正压通气的比较:一项随机前瞻性研究。

Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for transient tachypnea of newborn: a randomized, prospective study.

作者信息

Demirel Gamze, Uras Nurdan, Celik Istemi Han, Canpolat Fuat Emre, Dilmen Ugur

机构信息

Samsun Maternity and Child Health Hospital, Division of Neonatology, Samsun, Turkey.

出版信息

J Matern Fetal Neonatal Med. 2013 Jul;26(11):1099-102. doi: 10.3109/14767058.2013.766707. Epub 2013 Feb 27.

Abstract

OBJECTIVE

To evaluate the efficacy of nasal intermittent mandatory ventilation (NIMV) in reducing the duration of respiratory distress compared with nasal continuous positive airway pressure (NCPAP) in transient tachypnea of the newborn (TTN).

PATIENT AND METHODS

In this randomized-prospective study, 40 infants with a gestational age ≥ 37 weeks and birth weight ≥ 2000 g with TTN were randomized to either nonsynchronized NIMV (n = 20) or NCPAP (n = 20). The primary end point was the reduction of the duration of respiratory distress. Secondary end points were the duration and level of oxygen supplementation, the incidence of complications such as pneumothorax, pneumonia and respiratory failure requiring entubation.

RESULTS

There were no significant difference in the duration of respiratory support (28.0 ± 19.2 h versus 32.2 ± 23.3 h, p = 0.231), O2 therapy (31.2 ± 15.6 h versus 29.0 ± 19.3 h, p = 0.187), duration of TTN (67.6 ± 36.5 h versus 63.3 ± 39.1 h, p = 0.480) and hospitalization (6.2 ± 2.6 d versus 5.4 ± 2.0 d, p = 0.330) between the groups. The rate of complications were not significantly different between the groups.

CONCLUSION

Our study indicates that NIMV is well tolerated and as effective as NCPAP in the treatment of TTN.

摘要

目的

评估在新生儿短暂性呼吸急促(TTN)中,与经鼻持续气道正压通气(NCPAP)相比,经鼻间歇强制通气(NIMV)在缩短呼吸窘迫持续时间方面的疗效。

患者与方法

在这项随机前瞻性研究中,将40例胎龄≥37周、出生体重≥2000g且患有TTN的婴儿随机分为非同步NIMV组(n = 20)和NCPAP组(n = 20)。主要终点是呼吸窘迫持续时间的缩短。次要终点是吸氧的持续时间和水平、气胸、肺炎及需要插管的呼吸衰竭等并发症的发生率。

结果

两组在呼吸支持持续时间(28.0±19.2小时对32.2±23.3小时,p = 0.231)、氧疗(31.2±15.6小时对29.0±19.3小时,p = 0.187)、TTN持续时间(67.6±36.5小时对63.3±39.1小时,p = 0.480)和住院时间(6.2±2.6天对5.4±2.0天,p = 0.330)方面无显著差异。两组并发症发生率无显著差异。

结论

我们的研究表明,NIMV耐受性良好,在治疗TTN方面与NCPAP效果相同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验